Critical role of TLR4 in human metapneumovirus mediated innate immune responses and disease pathogenesis

Thangam Sudha Velayutham1, Deepthi Kolli, Teodora Ivanciuc

  • 1Department of Pediatrics, University of Texas Medical Branch, Galveston, Texas, United States of America.

Plos One
|November 9, 2013
PubMed

Insights

Toll-like receptor 4 (TLR4) activation exacerbates human metapneumovirus (hMPV) disease severity by increasing inflammation. However, TLR4 deficiency reduces hMPV disease symptoms without impacting viral clearance or protective immunity.

Area of Science:

  • Immunology
  • Virology
  • Respiratory Medicine

Background:

  • Human metapneumovirus (hMPV) causes significant respiratory illness in vulnerable populations.
  • Toll-like receptors (TLRs) are key in innate immunity against viral infections.
  • Toll-like receptor 4 (TLR4) mediates hMPV-induced immune responses in dendritic cells.

Purpose of the Study:

  • To investigate the role of TLR4 in hMPV-induced disease pathogenesis.
  • To determine if TLR4 deficiency affects clinical outcomes, immune cell recruitment, or viral control during hMPV infection.

Main Methods:

  • Infection of wild-type and TLR4-deficient mice with hMPV.
  • Assessment of clinical disease parameters (body weight loss, airway obstruction).
  • Analysis of viral clearance, lung inflammation, immune cell infiltration, T-cell proliferation, and antibody production.

Main Results:

  • TLR4-deficient mice exhibited significantly reduced disease severity, including less weight loss and airway hyperresponsiveness.
  • Inflammatory responses, cytokine/chemokine levels, and immune cell recruitment were significantly lower in TLR4-deficient mice.
  • Viral replication, clearance, T-cell proliferation, and neutralizing antibody production were unaffected by TLR4 deficiency.

Conclusions:

  • TLR4 is crucial for initiating the innate immune response to hMPV.
  • TLR4 contributes to hMPV disease pathogenesis by amplifying inflammation.
  • Blocking TLR4 signaling may reduce hMPV disease severity without compromising antiviral protection.

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.4K
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more...
144
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.7K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
3.1K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.7K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
65.0K